arrow
É

Édouard Auclin

AP-HP
H指数:31
被引数:5,680

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated Prognostic Score in Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel – A CABASTY Post Hoc Analysis Validated by Two International Prospective Phase 3 Trials

集成预后评分在卡巴他赛治疗转移性去势抵抗性前列腺癌中的应用——CABASTY事后分析并由两项国际前瞻性III期试验验证

2026-04-220
OAAI
Real-World Outcomes of First-Line Immune-Based Combination Therapies in Bone-Metastatic Clear Cell Renal Cell Carcinoma

骨转移性透明细胞肾细胞癌中一线免疫为基础的联合疗法真实世界结局

2026-02-011
OA
Clinical and Pathological Features Associated with Chromophobe Renal Cell Carcinoma Recurrence: Analysis from a Nationwide Cohort

与嗜色细胞肾细胞癌复发相关的临床和病理特征:全国队列分析

2025-11-130
OAAI
Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study)

驱动基因致癌突变在非小细胞肺癌中的频率及欧洲室内氡暴露的估计(RADON EUROPE研究)

2025-06-260
OA
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)

简报:循环肿瘤DNA下一代测序在晚期肺鳞癌患者中的临床实用性(SQUIN)

2025-02-140
PRE
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
2024-09-014
OAAI
Activity of brigatinib based on genomic alterations detected on ctDNA at baseline and at progression in ALK inhibitor-naive advanced ALK plus NSCLC from the ALTA-1L trial

基于ALTA-1L试验中ALK抑制剂初治晚期ALK阳性NSCLC患者基线和进展时ctDNA检测的基因组改变评估brigatinib的活性

2024-09-010
PRE
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer
2024-05-014
PRE
A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability

一项多中心研究评估免疫检查点抑制剂在具有微卫星不稳定性的晚期非结直肠消化道癌中的疗效

2024-05-013
OA
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study
2023-12-153
PRE
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study
2023-11-011
PRE
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort

免疫检查点抑制剂在微卫星不稳定/错配修复缺陷的晚期胰腺癌中的疗效: 一个AGEO欧洲队列

2023-07-0125
PRE